Suppr超能文献

中国人结直肠癌患者微卫星 DNA、p53、APC 和 K-ras 的 DNA 改变。

DNA alterations of microsatellite DNA, p53, APC and K-ras in Chinese colorectal cancer patients.

机构信息

Graduate School, Chinese Academy of Medical Sciences & Peking Union Medical College, Dongdan, Dongcheng District, Beijing, China.

出版信息

Eur J Clin Invest. 2012 Jul;42(7):751-9. doi: 10.1111/j.1365-2362.2011.02641.x. Epub 2012 Feb 11.

Abstract

BACKGROUND

Colorectal cancer is one of the most rapidly increasing cancers in the world, and accumulation of alterations in oncogenes, tumour suppressor genes and mismatch repair (MMR) genes contributes to colorectal tumorigenesis. Thus, we investigated the alterations of 14 microsatellite loci adjacent to MMR genes, p53, adenomatous polyposis coli (APC) and K-ras in 52 Chinese patients with colorectal cancer.

MATERIALS AND METHODS

We performed fluorescent polymerase chain reaction and capillary electrophoresis to analyse microsatellite instability (MSI) and loss of heterozygosity (LOH) in microsatellite loci, which included a panel of nine dinucleotide repeats and the Bethesda consensus panel. Additionally, we screened for mutations in exons 4-9 of p53 and the mutation cluster region (MCR) in APC by DHPLC. Codons 12, 13 and 61 in K-ras were analysed using direct sequencing. All variations were confirmed using clone sequencing.

RESULTS

The alteration frequency of microsatellite DNA was 55·8% (29/52). Among the microsatellites, five loci exhibited MSI and another nine loci exhibited LOH. The mutation rates of p53, APC and K-ras were 42·3%, 38·5% and 36·5%, respectively. All patients (n = 7) with liver metastasis had a mutation in p53, APC or K-ras. APC mutation was correlated with clinical stage and the presence of lymph node metastasis (P = 0·001 and P = 0·006, respectively). CONCLUSIONS>   A total of 80·8% of Chinese patients with colorectal cancer show variations in microsatellite DNA, p53, APC or K-ras. It appears that these microsatellite DNA alterations could be a new biomarker for colorectal cancer.

摘要

背景

结直肠癌是世界上增长最快的癌症之一,癌基因、肿瘤抑制基因和错配修复(MMR)基因的改变导致结直肠肿瘤的发生。因此,我们检测了 52 例中国结直肠癌患者中 14 个紧邻 MMR 基因、p53、腺瘤性结肠息肉病(APC)和 K-ras 的微卫星位点的改变。

材料与方法

我们采用荧光聚合酶链反应和毛细管电泳技术分析微卫星不稳定性(MSI)和微卫星位点杂合性丢失(LOH),包括一组九个二核苷酸重复序列和贝塞斯达共识面板。此外,我们通过 DHPLC 筛选 p53 外显子 4-9 和 APC 突变簇区(MCR)的突变。采用直接测序分析 K-ras 密码子 12、13 和 61。所有变异均通过克隆测序确认。

结果

微卫星 DNA 的改变频率为 55.8%(29/52)。在微卫星中,有 5 个位点表现出 MSI,9 个位点表现出 LOH。p53、APC 和 K-ras 的突变率分别为 42.3%、38.5%和 36.5%。所有(n=7)有肝转移的患者均存在 p53、APC 或 K-ras 的突变。APC 突变与临床分期和淋巴结转移有关(P=0.001 和 P=0.006)。

结论

80.8%的中国结直肠癌患者存在微卫星 DNA、p53、APC 或 K-ras 的改变。这些微卫星 DNA 的改变可能是结直肠癌的一个新的生物标志物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验